Recent Finacing
Recent Raise
ImmunOs Therapeutics is a Swiss biotech developing HLA-based multitarget fusion proteins to modulate innate and adaptive immunity, advancing IOS-1002 (iosH2) in clinical trials for cancer and autoimmune disease.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at ImmunOs Therapeutics.
